Tang Capital Management’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $4.35M | Buy |
|
|||||
|
2025
Q2 | $4.42M | Sell |
|
|||||
|
2025
Q1 | $4.92M | Buy |
|
|||||
|
2024
Q4 | $3.27M | Buy |
|
|||||
|
2024
Q3 | $3.68M | Hold |
|
|||||
|
2024
Q2 | $6.47M | Hold |
|
|||||
|
2024
Q1 | $5.12M | Hold |
|
|||||
|
2023
Q4 | $3.15M | Hold |
|
|||||
|
2023
Q3 | $1.91M | Hold |
|
|||||
|
2023
Q2 | $2.15M | Buy |
|
|||||
|
2023
Q1 | $831K | Sell |
|
|||||
|
2022
Q4 | $9.39M | Sell |
|
|||||
|
2022
Q3 | $28.9M | Buy |
|
|||||
|
2022
Q2 | $10.4M | Hold |
|
|||||
|
2022
Q1 | $21.3M | Sell |
|
|||||
|
2021
Q4 | $71.1M | Sell |
|
|||||
|
2021
Q3 | $84.5M | Hold |
|
|||||
|
2021
Q2 | $123M | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $42.9M | Hold |
|
|||||
|
2020
Q2 | $42.6M | Hold |
|
|||||
|
2020
Q1 | $34M | Sell |
|
|||||
|
2019
Q4 | $118M | Sell |
|
|||||
|
2019
Q3 | $102M | Sell |
|
|||||
|
2019
Q2 | $107M | Hold |
|
|||||
|
2019
Q1 | $140M | Sell |
|
|||||
|
2018
Q4 | $151M | Sell |
|
|||||
|
2018
Q3 | $188M | Sell |
|
|||||
|
2018
Q2 | $336M | Sell |
|
|||||
|
2018
Q1 | $239M | Buy |
|
|||||
|
2017
Q4 | $153M | Sell |
|
|||||
|
2017
Q3 | $140M | Hold |
|
|||||
|
2017
Q2 | $120M | Sell |
|
|||||
|
2017
Q1 | $130M | Buy |
|
|||||
|
2016
Q4 | $81.2M | Hold |
|
|||||
|
2016
Q3 | $107M | Hold |
|
|||||
|
2016
Q2 | $112M | Buy |
|
|||||
|
2016
Q1 | $98.6M | Hold |
|
|||||
|
2015
Q4 | $139M | Hold |
|
|||||
|
2015
Q3 | $127M | Hold |
|
|||||
|
2015
Q2 | $162M | Buy |
|
|||||
|
2015
Q1 | $71.6M | Hold |
|
|||||
|
2014
Q4 | $49.5M | Hold |
|
|||||
|
2014
Q3 | $41M | Hold |
|
|||||
|
2014
Q2 | $60.6M | Buy |
|
|||||
|
2014
Q1 | $61.3M | Buy |
|